A Study to Evaluate the Efficacy and Safety of Vismodegib in Combination With Ruxolitinib for the Treatment of Intermediate- or High-Risk Myelofibrosis (MF)
Clinical trial NCT02593760 · COMPLETED
Trial details
- NCT number
- NCT02593760
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-25
- Primary completion
- 2017-03-29
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.